Potomac, MD, United States of America

Haydar Celik

This inventor holds 1 USPTO granted patent. Top assignee: Georgetown University. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haydar Celik. Retrieved from https://idiyas.com/inventor/haydar-celik-o98znohv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haydar Celik: Innovator in Cancer Treatment

Introduction

Haydar Celik is a prominent inventor based in Potomac, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. His work focuses on developing methods to combat bone and connective tissue cancers.

Latest Patents

Haydar Celik holds a patent for "CD99 inhibitors and their uses." This patent outlines methods for treating bone or connective tissue cancer in a subject. The methods involve administering an effective amount of a CD99 inhibitor, which is a compound with a specific chemical formula. The patent emphasizes the potential of these inhibitors in providing therapeutic benefits for patients suffering from these types of cancers.

Career Highlights

Celik is affiliated with Georgetown University, where he conducts research and collaborates with other experts in the field. His work has garnered attention for its potential impact on cancer therapies, showcasing his dedication to advancing medical science.

Collaborations

Haydar Celik has worked alongside notable colleagues, including Aykut Üren and Jeffrey A Toretsky. These collaborations have further enriched his research and contributed to the development of innovative treatment methods.

Conclusion

Haydar Celik's contributions to cancer treatment through his patented inventions highlight his role as a key innovator in the medical field. His work continues to inspire advancements in therapeutic approaches for challenging diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…